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ABSTRACT 
 
In the present study, a series of chalcones were prepared by Claisen Schmidt condensation as 
starting compounds and 2-pyrazoline derivatives have been synthesized by the reaction of chalcones 
with thiosemicarbazide. Their structures have been confirmed by IR, 
1H-NMR, mass spectral data and 
elemental analysis. These synthesized 2-pyrazoline compounds have been tested in vivo anticonvulsant 
activity by using pentylenetetrazole (PTZ) induced seizure and maximal electroshock (MES) seizure 
tests at a dose of 50 mg/kg. None of the compounds have in vivo anticonvulsant properties in PTZ test 
whereas some compounds showed in vivo anticonvulsant activity in MES test. Therefore, 2-pyrazoline 
compounds have a promising in vivo anticonvulsant activity especially on generalized absence sei-
zures. 
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ŞALKONLARDAN TÜRETİLEN BAZI 2 –PİRAZOLİNLERİN SENTEZİ VE 
ANTİKONVULSAN AKTİVİTELERİ 
 
ÖZ 
 
Bu çalışmada, başlangıç maddesi olarak bir seri şalkon, Claisen Schmidt kondensasyonu kul-
lanılarak hazırlanmış ve bu şalkonların tiyosemikarbazid ile reaksiyonu sonucu 2-pirazolin türevleri 
sentezlenmiştir. Bileşiklerin kimyasal yapıları IR, 
1H-NMR ve kütle gibi spektral yöntemler ve ele-
mentel analiz yöntemi kullanılarak kanıtlanmıştır. Sentezlenen bu 2-pirazolin türevlerinin in vivo an-
tikonvulsan aktiviteleri, pentilentetrazol (PTZ) ve maksimal elektroşok (MES) ile uyarılmış nöbetlere 
karşı 50 mg/kg dozda test edilmiştir. Hiçbir bileşik PTZ testinde herhangi bir in vivo antikonvulsan 
özellik göstermemesine karşın, bazı bileşikler MES testinde  in  vivo antikonvulsan aktivite göster-
mişlerdir. Dolayısıyla 2-pirazolin türevleri özellikle generalize absens nöbetlerine karşı ümit verici in 
vivo antikonvulsan aktiviteye sahiptirler. 
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1. INTRODUCTION 
 
Epilepsy is a common and serious chronic 
neurological disorder characterized by recurring 
seizures (Munjal, et al., 2008). Although several 
drugs are in use for the treatment of epilepsy, 
they  are  not  effective  enough.  Therefore  re-
searchers  in  medicinal  chemistry  are  still  pro-
ceeding to study on potential compounds (Stefan 
and Feuerstein, 2007; Siddiqui and Ahsan, 2010; 
Guan, et al., 2010). 
 Among  these  compounds,  2-pyrazolines  are 
promising  structure  as  a  anticonvulsant  agents 
(Küçükgüzel, et al., 2000; Özdemir et al., 2007; 
Nikhil and Kishore, 2010). Pyrazoles and their 
reduced forms, pyrazolines, are well known ni-
trogen  containing  heterocylic  compounds  and 
various  methods  have  been  reported  for  their 
syntheses (Abid, et al., 2009). 
 
In the present study, a series of chalcones 
were prepared by Claisen Schmidt condensation 
as starting compounds and 2-pyrazoline deriva-
tives have been synthesized by the reaction of 
chalcones  with  thiosemicarbazide.  Among  the 
synthesized compounds, two of nine chalcones 
and  six  of  seven  2-pyrazolines  are  new  com-
pounds and their structures have been confirmed 
by IR, 
1H-NMR, mass spectral data and elemen-
tal analysis. 2-Pyrazolines have been tested anti-
convulsant activity by using pentylenetetrazole 
induced  seizure  (PTZ)  and  maximal  electro-
shock seizure (MES) tests. 
 
2. EXPERIMENTAL 
 
2.1 Chemistry 
 
Chemicals  were  procured  from  Aldrich 
Chemical Co. The reactions were monitored on 
Merck  pre-coated  aluminium  TLC  plates  60F-
254  and  the  products  were  visualized  by  UV-
light using chloroform and methanol as solvent 
system.  Melting  points  were  determined  on  a 
Schmelzpunktbestimmer SMP II apparatus and 
are uncorrected. The IR spectra were recorded 
on a Schimadzu FTIR 8400S spectrometry. 
1H 
NMR  spectra  were  recorded  on  Bruker  (400 
MHz)  spectrometer  instruments,  in  DMSO. 
Chemical shifts were recorded in parts per mil-
lion downfield from tetramethylsilane. The split-
ting patterns of 
1H-NMR were designed as fol-
lows: s: singlet, d: doublet, t: triplet, q: quartet, 
m:  multiplet.  The  mass  spectrometry  was  re-
corded  on  LC–MS-Agilent  1100  series  in  the 
electrospray mode. Elemental analysis was per-
formed on Leco CHNS-932 analyzer. 
 
2.1.1  General  Procedure  of  Preparation 
of Chalcones (1a-g). 
 
A mixture of 4-Pyridyl carboxaldehyde (50 
mmol),  aromatic  ketone  (50  mmol)  and  50% 
aqueous sodium hydroxide (30 mL) in methanol 
(150 mL)  was stirred at  room temperature for 
about 8 h. The resulting solid was crushed on 
ice-water, filtered and crystallized from MeOH 
(Satyanarayana et al., 2004). 
 
Chalcone  derivatives  1a ( A e p p l i ,  e t  a l . ,  
1980) 1b (Vatsadze, et al., 2004), 1c (Buu-Hoi 
et  al.,  1962),  1e  (Basnet,  et  al.,  2007)  and  1f 
(Mamolo, et al., 1999) were known compounds. 
Compounds  1d a n d  1g  were  new  compounds 
and their structure determination was given be-
low. 
 
1-(5-Bromo-2-thienyl)-3-(4-pyridyl)-2-
propen-1-one  (1d):  Yield  82  %,  mp  197-200
 
oC, IR (cm
-1): 3101-3024 (Ar-CH), 2914 (CH), 
1637  (C=O),  1593  (C=C),  1410  (C=N), 
1H-
NMR (400 MHz, DMSO-d6, δ, ppm): 7.42 (2H, 
dd, J=4.13 Hz, J= 8.57 Hz, CH=CH), 7.73 (1H, 
d, J: 4.22 Hz, H3 proton of thiophen), 8.15 (1H, 
d, J: 4.33 Hz, H4 proton of thiophen), 8.42 (2H, 
d, J=7.66 Hz, H2 and H6 protons of pyridine ) 
8.60 (2H, d, J= 7.75 Hz, H3 and H5 protons of 
pyridine).  Anal.  Calcd.  for  C12H8BrNOS:  C, 
49.00;  H,  2.74;  N,  4.76;  S,  10.90.  Found:  C, 
45.87; H, 2.75; N, 3.46, S,11.97.  
 
1-(2-Pyrrolyl)-3-(4-pyridyl)-  2-propen-1-one 
(1g):  Yield  60  %,  mp  232-233
oC,  IR  (cm
-1): 
3100-3030  (Ar-CH),  2930  (CH),  1640  (C=O), 
1595 (C=C), 1410 (C=N), 
1H-NMR (400 MHz, 
DMSO-d6, δ, ppm): 6.06 (1H, s, H4 proton of 
pyrrole), 6.40 (1H, s, H3 proton of pyrrole), 6.83 
(1H,  s,  H5  proton  of  pyrrole),  7.46  (2H,  dd, 
J=4.21 Hz, J= 8.39 Hz, CH=CH ); 8.18 (2H, d, 
J=8.66 Hz, H2 and H6 protons of pyridine) 8.37 
(2H, d, J= 8.75 Hz, H3 and H5 protons of pyri-
dine).  11.45  (1H,  s,  NH  of    pyrrole).  Anal. 
Calcd.  for  C12H10N2O:  C,  72.71;  H,  5.08;  N, 
14.13. Found: C, 72.80; H, 4.75; N, 13.46. 
 
2.1.2 General Procedure of Preparation 
of 5-(4-Pyridyl)-3-aryl-1-
thiocarbamoyl-2-pyrazolines (2a-g). 
 
A  mixture  of  chalcone  (1a-g)  (0.01  mol), 
thiosemicarbazide (0.012 mol) and NaOH (1 g, 
0.025 mol) was refluxed in ethanol (50 mL) for 
8 h. The products were poured into crushed ice 
and the solid mass which separated out was fil-
tered, dried and crystallized from an appropriate 
solvents (Özdemir, et al., 2007). Anadolu University Journal of Science and Technology - C 1 (2) 
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Compound 2a has been synthesized by Öz-
demir et al., (2007) as an intermediate product 
but the structure determination was made firstly 
in this research.  
 
5-(4-Pyridyl)-3-(2-thienyl)-1-thiocarbamoyl-
2-pyrazoline (2a): Yield 60%, mp 210-212 
oC, 
IR (cm
-1); 3430, 3206 (NH), 1590 (C=N), 1180 
(C=S),   
1H-NMR  (400  MHz,  DMSO-d6,  δ, 
ppm): 3.20 (1H, dd, HA, JAB= 17.60 Hz, JAX= 
3.61 Hz), 3.60 (1H, dd, HB, JAB= 17.67 Hz, JBX= 
11.47  Hz),  6.15  (1H,  HX,  JAX=  3.55  Hz,  JBX= 
11.41 Hz), 6.70 (1H, t, H4 proton of thiophen), 
6.90 (1H, d, J= 3.26 Hz, H3 proton of thiophen), 
7.10 (1H, bs, NH), 7.69 (1H, d, 4.81 Hz, H5 pro-
ton of thiophen ), 7.80 (1H, bs, NH), 8.40 (2H, 
d, J= 8.50 Hz, H3 and H5 protons of pyridine ), 
8.60 (2H, d, J= 8.50 Hz, H2 and H6 protons of 
pyridine).  Anal.  Calcd.  for  C13H12N4S2:  C, 
54.14; H, 4.19; N, 19.43; S, 22.24. Found: C, 
54.54;  H,  4.83;  N,  19.81;  S,  21.90.  MS-ES: 
289.39 (MH
+). 
 
5-(4-Pyridyl)-3-(4-pyridyl)-1-thiocarbamoyl-
2-pyrazoline (2b): Yield 40%, mp 198-202 
oC, 
IR (cm
-1); 3400, 3210 (NH), 1585 (C=N), 1160 
(C=S),   
1H-NMR  (400  MHz,  DMSO-d6,  δ, 
ppm): 3.20 (1H, dd, HA, JAB= 17.60 Hz, JAX= 
3.61 Hz), 3.60 (1H, dd, HB, JAB= 17.67 Hz, JBX= 
11.47  Hz),  6.15  (1H,  HX,  JAX=  3.55  Hz,  JBX= 
11.41  Hz),  7.10  (1H,  bs,  NH),  7.80  (1H,  bs, 
NH), 8.02 (2H, d, J=7.60 Hz, H3 and H5 protons 
of pyridine ), 8.40 (2H, d, J= 8.50 Hz, H2 and H6 
protons of pyridine), 8.60 (2H, d, J= 8.50 Hz, H3 
and H5 protons of pyridine), 8.83 (2H, d, J= 7.60 
Hz, H2 and H6 protons of pyridine). Anal. Calcd. 
for C14H13N5S: C, 59.34; H, 4.62; N, 24.72; S, 
11.32. Found: C, 587.54; H, 4.83; N, 25.10; S, 
11.82. MS-ES: 284.35 (MH
+). 
 
5-(4-Pyridyl)-3-(5-chloro-2-thienyl)-1-
thiocarbamoyl-2-pyrazoline  (2c):  Yield  45%, 
mp  204-206 
oC,  IR  (cm
-1);  3380,  3230  (NH), 
1595 (C=N), 1140 (C=S),  
1H-NMR (400 MHz, 
DMSO-d6,  δ,  ppm):  3.15  (1H,  dd,  HA,  JAB= 
17.60 Hz, JAX= 3.61 Hz), 3.30 (1H, dd, HB, JAB= 
17.67 Hz, J BX= 11.47 Hz), 6.05 (1H, HX, JAX= 
3.55 Hz, JBX= 11.41 Hz), 6.70 (1H, d, J= 4.20 
Hz, H3 proton of thiophen), 6.90 (1H, bs, NH), 
7.10 (1H, bs, NH), 7.41 (2H, d, J=7.50 Hz, H3 
and  H5 p r o t o n s  o f  p yr i d i n e ) ,  7 . 9 0  ( 1 H ,  d ,   J = 
4.26 Hz, H4 proton of thiophen), 8.60 (2H, d, J= 
8.50 Hz, H2 and H6 protons of pyridine). Anal. 
Calcd. for C13H11 ClN4S2: C, 48.36; H, 3.43; N, 
17.35; S, 19.86. Found: C, 47.54; H, 3.83; N, 
17.81; S, 19.82. MS-ES: 323.83 (MH
+). 
 
5-(4-Pyridyl)-3-(5-bromo-2-thienyl)-1-
thiocarbamoyl-2-pyrazoline (2d):  Yield 65%, 
mp  214-216 
oC,  IR  (cm
-1);  3420,  3230  (NH), 
1560 (C=N), 1145 (C=S),  
1H-NMR (400 MHz, 
DMSO-d6,  δ,  ppm):  3.10  (1H,  dd,  HA,  JAB= 
17.60 Hz, JAX= 3.61 Hz), 3.40 (1H, dd, HB, JAB= 
17.67 Hz, J BX= 11.47 Hz), 6.10 (1H, HX, JAX= 
3.55 Hz, JBX= 11.41 Hz), 6.20 (1H, d, J= 3.40 
Hz, H3 proton of thiophen), 6.90 (1H, d,  J= 3.42 
Hz, H4 proton of thiophen), 6.90 (1H, bs, NH), 
7.20 (1H, bs, NH), 7.35 (2H, d, J=7.50 Hz, H3 
and H5 protons of pyridine), 8.20 (2H, d, J= 8.50 
Hz, H2 and H6 protons of pyridine). Anal. Calcd. 
for C13H11 BrN4S2: C, 42.51; H, 3.02; N, 15.25; 
S, 17.46. Found: C, 42.54; H, 3.83; N, 15.81; S, 
17.84. MS-ES: 368.28 (MH
+). 
 
5-(4-Pyridyl)-3-(2-furyl)-1-thiocarbamoyl-2-
pyrazoline (2e): Yield 72%, mp 165-168 
oC, IR 
(cm
-1);  3380,  3210  (NH),  1560  (C=N),  1165 
(C=S),   
1H-NMR  (400  MHz,  DMSO-d6,  δ, 
ppm): 3.40 (1H, dd, HA, JAB= 17.60 Hz, JAX= 
3.61 Hz), 3.60 (1H, dd, HB, JAB= 17.67 Hz, JBX= 
11.47  Hz),  6.10  (1H,  HX,  JAX=  3.55  Hz,  JBX= 
11.41  Hz),  6.35  (1H,  m,  H4  proton  of  furan), 
6.60 (1H, d,  J: 3.15 Hz, H3 proton of furan), 
7.35 (1H, d, J= 3.20 Hz, H5 proton of furan), 
6.90 (2H, bs, NH2), 7.41 (2H, d, J=7.50 Hz, H3 
and H5 protons of pyridine), 8.60 (2H, d, J= 8.50 
Hz, H2 and H6 protons of pyridine). Anal. Calcd. 
for C13H12N4OS: C, 57.34; H, 4.44; N, 20.57; S, 
11.77. Found: C, 57.54; H, 4.83; N, 20.82; S, 
11.78. MS-ES: 273.32 (MH
+). 
 
5-(4-Pyridyl)-3-phenyl-1-thiocarbamoyl-2-
pyrazoline (2f): Yield 65%, mp 186-188 
oC, IR 
(cm
-1);  3410,  3250  (NH),  1570  (C=N),  1130 
(C=S),   
1H-NMR  (400  MHz,  DMSO-d6,  δ, 
ppm): 3.15 (1H, dd, HA, JAB= 17.30 Hz, JAX= 
3.41 Hz), 3.30 (1H, dd, HB, JAB= 17.30 Hz, JBX= 
11.50  Hz),  6.10  (1H,  HX,  JAX=  3.50  Hz,  JBX= 
11.48  Hz),  6.50  (1H,  bs,  NH),  7.10  (1H,  bs, 
NH), 7.30-7.60 (7H, m, phenyl protons, H3 and 
H5 protons of pyridine), 8.60 (2H, d, J= 8.50 Hz, 
H2 and H6 protons of pyridine). Anal. Calcd. for 
C15H14N4S:  C,  63.80;  H,  5.00;  N,  19.84;  S, 
11.36. Found: C, 63.74; H, 4.83; N, 19.98; S, 
11.60. MS-ES: 283.36 (MH
+). 
 
5-(4-Pyridyl)-3-(2-pyrroyl)-1-thiocarbamoyl-
2-pyrazoline (2g): Yield 55%, mp 165-167 
oC, 
IR (cm
-1); 3390, 3200 (NH), 1580 (C=N), 1150 
(C=S),   
1H-NMR  (400  MHz,  DMSO-d6,  δ, 
ppm): 3.40 (1H, dd, HA, JAB= 17.60 Hz, JAX= 
3.61 Hz), 3.60 (1H, dd, HB, JAB= 17.67 Hz, JBX= 
11.47  Hz),  6.10  (1H,  HX,  JAX=  3.55  Hz,  JBX= 
11.41 Hz), 6.20 (1H, m, H4 proton of pyrrole), 
6.45 (1H, d, J= 3.30 Hz, H3 proton of pyrrole), Anadolu Üniversitesi Bilim ve Teknoloji Dergisi - C 1 (2) 
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6.80 (1H, d, J= 3.20 Hz, H5 proton of pyrrole), 
6.90 (2H, bs, NH2), 7.41 (2H, d, J=7.50 Hz, H3 
and H5 of pyridine), 8.60 (2H, d, J= 8.50 Hz, H2 
and H6 of pyridine), 11.20 (1H, s, NH of pyr-
role). Anal. Calcd. for C13H13N5S: C, 57.54; H, 
4.83; N, 25.81; S, 11.82. Found: C, 58.10; H, 
4.63; N, 24.88; S, 10.76. MS-ES: 272.34 (MH
+). 
 
2.2 Pharmacology 
 
Male and female adult Balb/C mice weigh-
ing 20-30 g were used. The animals were housed 
in  colongy  cages,  under  standard  laboratory 
conditions, with free access to food and tap wa-
ter.  Room  temperature  and  relative  humidity 
were maintained at 22 ± 1 
oC and 60% respec-
tively. A 12 hr/12 hour (8 A.M. /8 P.M.) light-
dark cycle was used. All testing was conducted 
in the light phase of the day. After the adaption 
period of 2 days, experimental groups were cho-
sen randomly. Each mouse was used only once. 
The  experimental  protocols  were  approved  by 
the  Animal  Care  and  Use  Committee  of  Mar-
mara University (16.04.2009-02.2009.mar). 
 
2.2.1 Anticonvulsant Activity 
 
The  anticonvulsant  activities  of  the  new 
compounds  were  determined  by  using  PTZ 
(Sigma) and MES tests. These rodent models are 
widely used as standard methods for predicting 
protection  against  generalized  absense  and 
tonic-clonic  seizures  in  humans  (Borowicz, 
2010). 
 
All synthesized compounds were suspended 
in 0.5 % methyl cellulose and administered at 
the dose of 50 mg/kg 30 minutes prior the tests. 
Effective  dose  50  (ED50)  value  for  PTZ  (60 
mg/kg)  and  convulsive  current  50  (CC50)  of 
animals and it’s 95% fiducial limits were calcu-
lated by the method of Litchfield and Wilcoxon 
(1949). 
 
Statistical  analysis  were  evaluated  using 
analysis of variance (ANOVA) followed by un-
paired Student’s t-test using Prism 3.0 (Graph-
Pad Software, San Diego; CA; USA). ED50 val-
ues, as well as their statistical evaluation, were 
estimated by computer probit analysis, accord-
ing to Litchfield and Wilcoxon (1949). 
 
 
 
2.2.1.1 PTZ test: 
 
The animals of the control group received 
same volume of saline and standart drugs were 
carbamazepine  (CARB)  in  PTZ  test.  Thirty 
minutes after the administration of the test com-
pounds, mice were injected with PTZ 60 mg/kg 
intraperitoneally  and  observed  for  15  minutes. 
Motor responses were graded 0-5 according to 
the scale of Racine where, grade 1: no move-
ments, grade 2: head twitching and myoclonic 
jerks  (MKJ),  grade  3:  clonic  forelimb  convul-
sions,  grade  4:  three  plus  change  in  posture, 
grade  5:  falling  back  and  generalized  convul-
sions with tonic extention (Racine, 1972). 
 
2.2.1.2 MES test: 
 
MES test was performed 30 minutes after 
the  administration  of  the  test  compounds.  The 
electroshocks  were  evoked  through  a  current 
transmitter  producing  square  waves  (Arı  Te-
chinical  ECT  unit).  In  the  MES  test,  seizures 
were elicited with a 60-Hz alternating current of 
25 mA intensity in Balb/c mice. The current was 
applied via ear clip electrodes for 450 mS. Dur-
ing the shock, electrodes were attached to each 
animal’s ears and the animals lay on their backs, 
their tails being fixed. Thus observation of the 
tonic and clonic convulsions that appeared dur-
ing the seizure was ensured (Krall, 1978). 
 
RESULTS AND DISCUSSION 
 
The synthetic route of target compounds 2a-
g  is  outlined  in  Scheme  1.  The  intermediated 
chalcones  (1a-g)  were  prepared  by  reacting 
equimolar aldehyde and ketone in presence of a 
base by conventional Claisen-Schmidt conden-
sation.  The chalcone derivatives 1d and 1g were 
original  compounds  and  their  chemical  struc-
tures were confirmed by 
1H-NMR and elemental 
analysis. The reaction of the chalcones with thi-
osemicarbazide in alkaline medium afforded the 
corresponding  5-(4-pyridyl)-3-aryl-1-
thiocarbamoyl-2-pyrazolines  (2a-g) .  T h e  c o m -
pounds 2a-g were isolated in satisfactory yields 
(40-72%) and purified by recrystallisation, using 
ethanol. The purity of the compounds was estab-
lished by thin layer chromatography (TLC) and 
elemental  analysis.  Their  chemical  structures 
were confirmed by IR, 
1H-NMR and mass (MS-
ES) spectral data. 
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Scheme 1. Synthetic route to the title compounds 
 
Ar:  2-thienyl  (1a,  2a),  4-pyridyl  (1b,  2b),  5-
chloro-2-thienyl (1c, 2c), 5-bromo-2-thienyl (1d, 
2d), 2-furyl (1e, 2e), phenyl (1f, 2f), 2-pyrrolyl 
(1g, 2g). 
 
The IR spectra of the compounds afforded 
pyrazoline  C=N  stretching  (1501-1576  cm
-1), 
thiocarbamoyl  group  N-H  stretching  (3430-
3210)  and  C=S  stretching  (1180-1130)  bands. 
The  CH2  protons  of  the  pyrazoline  ring  reso-
nated as a pair of doublets of doublets at 3.23-
3.58  ppm  (HA),  3.80-3.96  ppm  (HB).  The  CH 
(HX) proton appeared as a doublet of doublets at 
5.57-5.74 ppm due to vicinal coupling with the 
two magnetically non-equivalent protons of the 
methylene group at position 4 of the pyrazoline 
ring (JAB =17.1-17.6 Hz, JAX = 7.0-7.5 Hz, J BX 
=12.0-12.1  Hz).    N-H  protons  of  the  thiocar-
bamoyl group were seen at 6.50-7.90 ppm gen-
erally as broad bands. The protons belonging to 
the aromatic ring and the other aliphatic groups 
are  observed  with  the  expected  chemical  shift 
and  integral  values.  Mass  spectra  (MS-ES)  of 
compounds  showed  a  [MH]
+  peaks,  in  agree-
ment with their molecular formula. 
 
The anticonvulsant activities of the synthe-
sized compounds were determined by using PTZ 
and MES tests. All tested compounds were ad-
ministered at the dose of 50 mg/kg. The anti-
convulsant activity results were shown in Figure 
1 and 2. In PTZ induced convulsions although 
there is a tendency of anticonvulsant activity in 
terms of less Grade V seizures in 2b, 2d and 2g 
data was not statistically significant (Figure 1A) 
most probably because of high standard devia-
tion within the groups. None of the compounds 
found significant compaired to PTZ and CARB 
groups in terms of percentage of survival rate 
(Figure 1B) in the PTZ-induced seizure test. On 
the  other  hand,  compounds  5-(4-pyridyl)-3-(4-
pyridyl)-1-thiocarbamoyl-2-pyrazoline (2b) and 
5-(4-pyridyl)-  3-(2-furyl)-1-thiocarbamoyl-2-
pyrazoline ( 2 d )     prevented  MES  induced  sei-
zures (Figure 2A) but they were not able to re-
duce the mortality rate (Figure 2B).  
 
    In conclusion, the results of the present 
study demonstrate that 2-pyrazoline derivatives 
(2a-g)  may  have  potential  anticonvulsant  ef-
fects. None of the compounds have anticonvul-
sant  properties  in  PTZ-induced  seizure  test 
whereas  some  compounds  showed  anticonvul-
sant  activity  in  MES  test.  Therefore,  2-
pyrazoline  compounds  may  have  a  promising 
therapeutic  potential  especially  on  tonic-clonic 
convulsions. 
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Figure 1. The number of Grade V seizures (A) and percentage of survival rate (B) in the PTZ-induced 
seizure test. Each group consists of 6-10 mice and compounds were compaired to PTZ  and 
CARB groups. 
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Figure 2. The percentage of seizure prevention (A) and survival rate (B) in MES test (60 Hz, 25 mA, 
450mS). Each group consists of 6-10 mice. Compounds were compaired to conrol group and          
* p<0.05 considered significant. 
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